Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.
about
Estrogen signaling and the aging brain: context-dependent considerations for postmenopausal hormone therapyLong term hormone therapy for perimenopausal and postmenopausal womenThe periodic health examination: 2. 1987 update. Canadian Task Force on the Periodic Health ExaminationEstrogen receptor transcription and transactivation: Basic aspects of estrogen action.Perspectives on menopause and women with HIVRheumatology: 15. OsteoporosisLong-term hormone therapy for perimenopausal and postmenopausal women.Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice.Expression of adhesion molecules LFA-I and ICAM-I on osteoclast precursors during osteoclast differentiation and involvement of estrogen deficiency.The relationship between sex steroids and bone mineral content in women soon after the menopause.Population screening for osteoporosis to prevent fractures.Enhanced osteoblast proliferation and collagen gene expression by estradiol.That oestrogen replacement for osteoporosis prevention should no longer be a bone of contentionObstetrics and gynecology-important advances in clinical medicine: comparative risks of osteoporosis and endometrial cancer.Bones and Crohn's: problems and solutions.Osteoporosis: "A risk factor for periodontitis"Identification of androgen receptors in normal human osteoblast-like cells.Loading-related regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor alpha and disusePhysiology of bone loss.Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.Vitamin D deficient states. Pathophysiology and treatmentHip fracture, skeletal fragility, osteoporosis and hormonal deprivation in elderly women.Female reproductive system and bone.A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient miceComparative safety of bone remodeling agents with a focus on osteoporosis therapies.Bone changes occurring spontaneously and caused by estrogen in early postmenopausal women: a local or generalised phenomenon?Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapyHormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.Relevance of osteoporosis in women with fracture of the femoral neck.Low-dose hormone replacement therapy: effects on bone.Alterations in estrogen levels during development affects the skeleton: use of an animal model.Anti-oestrogenic prevention of breast cancer--the make or break point.Non-hormonal treatment of osteoporosisRisk factors for osteoporosis and associated fractures.Classic yin and yang tonic formula for osteopenia: study protocol for a randomized controlled trial.Osteoarthrosis of the knee in men and women in association with overweight, smoking, and hormone therapy.17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.
P2860
Q21284766-33EDB2BF-9B67-46F4-9B12-C6FD996800FBQ24201974-58062FE0-251B-491B-8C3E-53187E8F6EEAQ24535624-70691DB3-BB37-47D4-BA8A-693C1B96492BQ24800814-24D8E0D1-B37A-4715-8AD9-C5D5F75689E5Q26772852-6B9CA781-F3B9-4FFB-9964-6A82FE7E1E00Q28344803-E144F472-CECB-46E6-92E0-FBC68E5B09D7Q30238978-1593A063-D767-4987-8C7C-876699065094Q30649524-5F4E285E-E370-4C49-BC36-0AF7C294628BQ31044648-2148EC5E-8B32-4957-8330-B0242591655BQ33318817-F4E7B2B1-2FE8-4C28-8232-2DD01E2B8E8EQ33555630-B25CB835-6A2E-4A97-9EAE-411091C2292CQ33564462-5B88A5BA-A2FC-412D-9C89-F37CB05E0CA1Q33565228-ABCD3A65-6950-474F-86F3-4B320832E53BQ33605651-48CB742A-1C03-4C21-B000-9940E1360CF3Q33715520-DE682C31-678D-41BC-90D9-6880F382B831Q33759893-0D99372A-4E96-4506-8DD3-F4022E13E79EQ33834413-D6B8F7F4-3FED-465E-80F9-CAE24192D70DQ33920309-F9412174-74CA-4C98-ABA0-1F486A3A7021Q33980978-DBC9B98C-0C79-4D7C-84B9-981441F42DFFQ34070203-41A45D5C-1C79-4A3B-9BE1-15D33A514841Q34107683-504FFBE3-9BFA-4F9D-BBA6-CAF55BC7E7A5Q34108842-9D6BC0C3-6A11-427C-9CA1-DF2D8A72B0B5Q34142868-AAA0590F-8003-4AB9-87E9-575C8714084EQ34194419-3C8C5F9A-0701-442D-BB33-B66022694ED9Q34195727-15B60544-8E2F-4318-AE32-7A0B6234FCC2Q34285263-8350B728-B1B5-4830-8856-4C6F836252CBQ34328229-05C3EC64-3648-4F5D-A7A5-369249F421A8Q34343772-8F2F95F5-1860-4D53-B67D-FB2531C24B5AQ34369657-BF3FF6BF-365C-450A-9A29-60F824EDBD24Q34377588-AF1D4843-CAC0-4897-982D-BCC89A9057F8Q34555761-63739DBD-A219-4567-8413-84741C810AA3Q34672074-86DBA1B1-B834-40F6-BB89-FFEE74EC962FQ34831924-32D05A52-4734-4DF1-95D4-2860FA10D6B9Q34932305-7EAE932C-55AE-4846-8CD1-E17B1F8BB053Q34992183-91F09C65-6664-4318-8855-7E07CF5B5A20Q35055777-9281B238-E806-4296-BC30-2F1EF46D0BEFQ35206132-F606E216-A5D5-4D2A-8186-85A93B6C8C78Q35548476-FC3F1751-CFC9-467B-A295-DF3FAAD22385Q35599207-EE19B6EE-CEFE-4709-A3CA-EA384C378274Q35610407-8C2E6E0E-0727-4182-A058-B66DE48E97B7
P2860
Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Long-term prevention of postme ...... onset of oestrogen treatment.
@en
Long-term prevention of postme ...... onset of oestrogen treatment.
@nl
type
label
Long-term prevention of postme ...... onset of oestrogen treatment.
@en
Long-term prevention of postme ...... onset of oestrogen treatment.
@nl
prefLabel
Long-term prevention of postme ...... onset of oestrogen treatment.
@en
Long-term prevention of postme ...... onset of oestrogen treatment.
@nl
P2093
P1433
P1476
Long-term prevention of postme ...... onset of oestrogen treatment.
@en
P2093
A C Clarke
E B MacDonald
J B Anderson
J M Aitken
P304
P356
10.1016/S0140-6736(76)92217-0
P407
P577
1976-05-01T00:00:00Z